Status: Recruiting
A Study of [177Lu]Lu-A9-0631 and [225Ac]Ac-A9-0642 With [68Ga]Ga-A9-6217 or [177Lu]Lu-A9-0631 Imaging in GRPR+ Solid Tumors
This is a Phase 1-1b multicenter clinical study to evaluate the safety, efficacy, and dosimetry of \[177Lu\]Lu-A9-0631 and \[225Ac\]Ac-0642 in participants with Gastrin-Releasing Peptide Receptor (GRPR) expressing locally advanced, unresectable or metastatic solid tumors.
Participants needed: 115
Trial details
Phase: Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: Alpha-9 Oncology USA Inc.Updated: Jun 22, 2026Locations: 2
Eligibility criteria
Participant has provided written informed consent prior to any study-specific pr... [+7]
Received anticancer treatment including but not limited to chemotherapy, antibod... [+5]